Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Life and Health Insurance Industry Analysis

UpdatedAug 04, 2026
DataAggregated Company Financials
Companies21
  • 7D-0.5%
  • 3M15.7%
  • 1Y27.4%
  • YTDn/a

The Life and Health Insurance is pretty flat in the last 7 days, but Lincoln National has stood out, gaining 7.6%. As for the the longer term, the industry is up 27% over the past 12 months. Earnings are forecast to grow by 9.4% annually.

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 04 Aug 2026US$282.1bUS$265.7bUS$19.3b14.7x14.6x1.1x
Thu, 02 Jul 2026US$257.8bUS$264.8bUS$18.7b15.1x13.8x1x
Sat, 30 May 2026US$245.2bUS$264.8bUS$18.7b14.2x13.1x0.9x
Mon, 27 Apr 2026US$245.1bUS$260.3bUS$17.0b15.4x14.4x0.9x
Wed, 25 Mar 2026US$224.8bUS$260.7bUS$16.7b14.2x13.5x0.9x
Fri, 20 Feb 2026US$241.7bUS$261.2bUS$17.4b15.2x13.9x0.9x
Sun, 18 Jan 2026US$241.4bUS$255.6bUS$19.7b12.7x12.2x0.9x
Tue, 16 Dec 2025US$253.9bUS$255.6bUS$19.7b13.1x12.9x1x
Thu, 13 Nov 2025US$245.8bUS$255.7bUS$19.2b13.5x12.8x1x
Sat, 11 Oct 2025US$247.7bUS$254.5bUS$15.7b13.1x15.8x1x
Mon, 08 Sep 2025US$249.8bUS$254.5bUS$15.7b13.9x16x1x
Wed, 06 Aug 2025US$237.2bUS$255.6bUS$17.2b12.2x13.8x0.9x
Fri, 04 Jul 2025US$246.7bUS$257.6bUS$18.1b12.6x13.6x1x
Sun, 01 Jun 2025US$226.1bUS$243.3bUS$17.6b12.3x12.8x0.9x
Tue, 29 Apr 2025US$225.3bUS$249.9bUS$21.9b11x10.3x0.9x
Thu, 27 Mar 2025US$244.0bUS$250.3bUS$22.4b11.5x10.9x1x
Sat, 22 Feb 2025US$229.0bUS$249.2bUS$22.5b10.3x10.2x0.9x
Mon, 20 Jan 2025US$239.7bUS$242.9bUS$14.3b14.4x16.8x1x
Wed, 18 Dec 2024US$233.4bUS$242.9bUS$14.3b13.7x16.4x1x
Fri, 15 Nov 2024US$241.0bUS$242.9bUS$14.2b14.5x16.9x1x
Sun, 13 Oct 2024US$244.9bUS$229.8bUS$16.6b13.7x14.7x1.1x
Tue, 10 Sep 2024US$231.2bUS$229.8bUS$16.6b12.9x13.9x1x
Thu, 08 Aug 2024US$213.9bUS$227.9bUS$16.5b10.2x13x0.9x
Sat, 06 Jul 2024US$216.6bUS$225.3bUS$14.8b10.6x14.6x1x
Mon, 03 Jun 2024US$217.5bUS$225.4bUS$14.8b10.5x14.7x1x
Wed, 01 May 2024US$210.7bUS$218.4bUS$11.1b14.4x19x1x
Fri, 29 Mar 2024US$225.2bUS$216.9bUS$10.3b15.3x21.9x1x
Sun, 25 Feb 2024US$214.0bUS$216.4bUS$10.1b15.5x21.3x1x
Tue, 23 Jan 2024US$261.3bUS$213.6bUS$2.7b13.5x96.5x1.2x
Thu, 21 Dec 2023US$256.2bUS$216.4bUS$1.6b13.4x157.3x1.2x
Sat, 18 Nov 2023US$242.8bUS$216.4bUS$1.6b12.7x149.9x1.1x
Mon, 16 Oct 2023US$243.0bUS$238.9bUS$1.0b12.8x237.7x1x
Wed, 13 Sep 2023US$242.4bUS$238.9bUS$1.0b13x237.1x1x
Fri, 11 Aug 2023US$243.9bUS$238.9bUS$1.0b11.7x236.7x1x
Price to Earnings Ratio

236.7x


Total Market Cap: US$243.9bTotal Earnings: US$1.0bTotal Revenue: US$238.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life and Health Insurance Industry Price to Earnings3Y Average 40.9x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.6x which is lower than its 3-year average PE of 40.9x.
  • The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 166% per year over the last three years.
  • Revenues for these companies have grown 3.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?

US Market2.39%
Financials-0.28%
Insurance-2.91%
Life and Health Insurance-0.45%
General Insurance-1.32%
Insurance Brokers-2.37%
Property and Casualty Insurance-3.86%
Reinsurance-4.74%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LNC Lincoln NationalUS$46.097.6%
+US$634.1m		18.8%PE3.9x
GL Globe LifeUS$184.092.7%
+US$382.0m		32.0%PE11.8x
UNM Unum GroupUS$90.112.5%
+US$345.3m		28.7%PE20.3x
BNT Brookfield Wealth SolutionsUS$44.051.8%
+US$259.5m		-1.7%PE30.3x
CNO CNO Financial GroupUS$55.263.3%
+US$162.4m		52.5%PE21x

Latest News

UNM
US$90.11
Unum Group
7D
2.5%
1Y
28.7%
LNC
US$46.09
Lincoln National
7D
7.6%
1Y
18.8%
Seeking Alpha • Aug 01

Lincoln National's Reinsurance Deal Unlocks Further Upside

Summary Lincoln National executed a transformative $5.8B reinsurance deal, improving capital efficiency and freeing up resources for higher-return products. Q2 results were strong: EPS of $2.24 beat by $0.28, revenue grew 12%, and operating income rose for the 8th consecutive quarter. LNC’s capital actions, including preferred stock redemption and a secure 3.9% dividend, position it for resumed share repurchases and enhanced free cash flow. With a raised $50 price target and ongoing 'buy' rating, I see low-teens total return potential over the next year. Read the full article on Seeking Alpha
CNO
US$55.26
CNO Financial Group
7D
3.3%
1Y
52.5%
PFG
US$115.13
Principal Financial Group
7D
0.9%
1Y
51.2%
BHF
US$61.84
Brighthouse Financial
7D
-3.0%
1Y
32.2%
MET
US$96.31
MetLife
7D
-1.2%
1Y
28.6%
PRU
US$122.98
Prudential Financial
7D
-0.8%
1Y
19.2%
GL
US$184.09
Globe Life
7D
2.7%
1Y
32.0%
Narrative Update • Jul 28

GL: Earnings Miss Share Repurchases And Guidance Will Shape Future Returns

Analysts have raised their price target for Globe Life from $172.10 to approximately $190.09, reflecting updated models that incorporate a slightly higher discount rate, modestly different expectations for revenue growth and profit margins, and a higher assumed future P/E multiple. What’s in the News for Globe Life Globe Life shares fell 7.2% after reporting Q2 2026 net operating income of $3.61 per diluted share, which missed the $3.79 consensus estimate by 4.7%.
AFL
US$126.71
Aflac
7D
-2.2%
1Y
28.1%
Narrative Update • Jul 25

AFL: Future Returns Will Reflect Supportive Macro Conditions And Execution Risk Balancing

Aflac's fair value estimate has been raised from about $114.86 to $117.71 as analysts incorporate higher sector price targets, modestly higher assumed future P/E multiples, and a slightly stronger profit margin outlook supported by a more supportive macro backdrop and reduced private credit concerns across life insurers. Analyst Commentary Recent Street research on Aflac reflects a wide range of views on valuation and execution, even as most firms have adjusted their price targets upward in the run up to Q2 earnings.
OSCR
US$30.74
Oscar Health
7D
-2.1%
1Y
122.4%
Narrative Update • Jul 25

OSCR: ACA Exchange Risk Adjustment Tailwind Will Not Offset Margin Concerns

Analysts have lifted the implied fair value estimate for Oscar Health from $22.60 to $24.20, citing more supportive views on the 2025 healthcare exchange risk adjustment true up and the company’s focused exposure to the individual ACA market, even as margin expectations remain measured and the future P/E assumption edges up toward 11x. Analyst Commentary Recent research on Oscar Health centers on how the individual Affordable Care Act market, risk adjustment outcomes, and margin trajectory could feed into valuation over the next few years.
PRI
US$317.25
Primerica
7D
-1.4%
1Y
20.1%
Narrative Update • Jul 22

PRI: Future Returns Will Be Shaped By Buybacks And Stable Profitability

Analysts have nudged their average price target for Primerica higher, lifting fair value from $298.50 to about $308.67 as they update their models to reflect modestly adjusted assumptions for revenue growth, profit margin and future P/E expectations. What's in the News for Primerica Primerica was dropped from the Russell 1000 Dynamic Index, according to a key index constituent update.
BNT
US$44.05
Brookfield Wealth Solutions
7D
1.8%
1Y
-1.7%
GNW
US$9.82
Genworth Financial
7D
-2.4%
1Y
23.4%
FG
US$29.06
F&G Annuities & Life
7D
-4.6%
1Y
-10.3%